Cryoport - CYRX Stock Forecast, Price & News

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Cryoport Stock Performance

Shares of NASDAQ:CYRX opened at $45.00 on Friday. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of -7.28 and a beta of 1.13. The firm's 50 day simple moving average is $32.90 and its 200 day simple moving average is $31.36. The company has a debt-to-equity ratio of 0.73, a current ratio of 14.21 and a quick ratio of 13.69. Cryoport has a fifty-two week low of $19.82 and a fifty-two week high of $86.30.

Cryoport (NASDAQ:CYRX - Get Rating) last announced its earnings results on Thursday, August 4th. The consumer goods maker reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The company had revenue of $64.20 million for the quarter, compared to analyst estimates of $64.58 million. Cryoport had a negative return on equity of 14.43% and a negative net margin of 125.96%. The business's quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business posted ($0.16) earnings per share. As a group, sell-side analysts forecast that Cryoport will post -0.8 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Roth Capital cut their target price on shares of Cryoport from $90.00 to $67.00 in a research note on Tuesday, May 3rd. Needham & Company LLC increased their price objective on shares of Cryoport from $41.00 to $42.00 and gave the stock a "buy" rating in a report on Tuesday, July 12th. KeyCorp cut their target price on shares of Cryoport from $92.00 to $52.00 in a research report on Friday, May 6th. B. Riley cut their target price on shares of Cryoport from $61.00 to $55.00 in a research report on Tuesday, May 17th. Finally, BTIG Research cut their price target on shares of Cryoport from $95.00 to $60.00 in a research report on Friday, May 6th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Cryoport currently has a consensus rating of "Buy" and an average price target of $61.33.